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Abstract
Vacuolar-type H
+-ATPases (V-ATPases) are macromolecular proton pumps that acidify intracellular cargos and deliver
protons across the plasma membrane of a variety of specialized cells, including bone-resorbing osteoclasts. Extracellular
acidification is crucial for osteoclastic bone resorption, a process that initiates the dissolution of mineralized bone matrix.
While the importance of V-ATPases in osteoclastic resorptive function is well-defined, whether V-ATPases facilitate
additional aspects of osteoclast function and/or formation remains largely obscure. Here we report that the V-ATPase
accessory subunit Ac45 participates in both osteoclast formation and function. Using a siRNA-based approach, we show
that targeted suppression of Ac45 impairs intracellular acidification and endocytosis, both are prerequisite for osteoclastic
bone resorptive function in vitro. Interestingly, we find that knockdown of Ac45 also attenuates osteoclastogenesis owing to
a reduced fusion capacity of osteoclastic precursor cells. Finally, in an effort to gain more detailed insights into the
functional role of Ac45 in osteoclasts, we attempted to generate osteoclast-specific Ac45 conditional knockout mice using a
Cathepsin K-Cre-LoxP system. Surprisingly, however, insertion of the neomycin cassette in the Ac45-Flox
Neo mice resulted in
marked disturbances in CNS development and ensuing embryonic lethality thus precluding functional assessment of Ac45
in osteoclasts and peripheral bone tissues. Based on these unexpected findings we propose that, in addition to its canonical
function in V-ATPase-mediated acidification, Ac45 plays versatile roles during osteoclast formation and function.
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Introduction
The vacuolar-type H
+-ATPase (V-ATPase) is a highly conserved
plasma membrane protein complex that acidifies intracellular cargos
and pumps protons across the plasma membranes in numerous cell
types including osteoclasts, renal intercalated cells, epididymus and
tumour cells [1–4]. The complex consists of more than 16 subunits that
are divided into V1 and V0 domains [5–8]. The peripheral V1 domain
is composed of eight subunits (A–H) driving ATP hydrolysis.
Comparatively, the membrane bound V0 domain is comprised of six
distinct subunits (a, c, c9, c0, d and e) with six copies of the c/c9 subunits
and single copies of a, c0, d and e subunits. The V0 domain utilizes the
energy generated by the V1 domain to translocate protons across the
membrane. While the structural diversity of the V-ATPase complex
and tissue-specific isoforms have been shown to be associated with a
multitude of cellular processes, the precise gamut of functions regulated
by V-ATPases and their accessory subunits remain largely unclear.
Bone resorption by osteoclasts requires an ongoing secretion of
acid to dissolve mineralized bone matrix. The macromolecular V-
ATPase proton pump, located on the bone-apposed ruffled border
membrane of osteoclasts, is an established prerequisite for proton
secretion. Mutation, deletion or gene knockdown of different
subunits of the V-ATPase complex in osteoclasts have been shown
to severely impair osteoclastic bone resorption leading to severe
osteopetrosis in both mice and man [3,9–20]. Previously we and
others have shown that up- regulation of the d2 subunit of the V-
ATPase complex is not only required for bone resorption but also
facilitates osteoclast formation from committed precursors,
pointing to auxiliary functions for selective V-ATPase subunits
[13,21].
Ac45 is an accessory subunit of the V-ATPase V0 complex
originally isolated from bovine chromaffin granules and thought to
participate in the rotational catalysis of the V0 domain [22,23]. It
exists as a globular protrusion of the V0 domain with its C-
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towards the luminal side evidenced by electron and cryo-electron
microscopy [24–26]. In addition, the C-terminus of Ac45 carries a
26-amino acid (aa) residue domain that harbors an autonomous
internalization signals that is important for the regulation of
essential routing machinery and is necessary for efficient bone
resorption by osteoclasts [10,27].
To further explore the role of Ac45 in osteoclasts, we here
employed an RNA interference strategy to specifically suppress
Ac45 expression and investigate its impact on osteoclast formation
and function. Interesting, we provide evidence that along with
facilitating acidification and the up-take of endocytic markers,
Ac45 also regulates osteoclast formation. In addition, we
document the generation of osteoclast-specific Ac45 conditional
knockout (cKO) mice. However, these mice unexpectedly exhibit
marked disturbances in CNS development and ensuing embryonic
lethality owing to the insertion of the neomycin cassette in Ac45-
Flox
Neo mice thus precluding functional assessment of Ac45 in
osteoclasts and peripheral bone tissues. Nonetheless, our collective
in vitro findings highlight the remarkable yet versatile roles of Ac45
in osteoclast formation and bone resorption.
Results
siRNA-mediated knockdown of Ac45 impairs intracellular
acidification, endocytosis and osteoclastic bone
resorption in vitro
To investigate the function of Ac45 in osteoclasts we adopted a
siRNA-based approach to specifically knock-down Ac45 expression
in pre-fusion osteoclastic cells. Ac45 gene silencing was performed in
bone marrow derived pre-fusion osteoclasts stimulated with 100 ng/
ml RANKL for 3 days. Five different Ac45 siRNA oligonucleotides
were initially screened to assess their ability to effectively silence Ac45
mRNA expression. As shown in Figure 1A, siRNA Ac1 proved the
most effective in achieving a sustainable knockdown of Ac45 mRNA
expression by more than 50% 48hrs post-transfection of pre-fusion
osteoclasts which persisted upon multinucleated osteoclasts formation
(day 5).The remaining siRNAs were deemed to have limited (,25%)
to no effect on Ac45 mRNA expression levels (Fig. 1A) and thus
excluded from use in subsequent experiments. Herein, the Ac1
siRNA is designated as Ac45 siRNA for subsequent investigations
into the role of Ac45 in osteoclast differentiation and function in vitro.
Pre-fusion osteoclasts were transfected with 100nM Ac45 or control
siRNAs and cultured with RANKL and M-CSF for 48hrs to induce
mature osteoclast formation, as evidenced by the presence of
calcitonin receptor gene expression (Fig. 1B). In mature osteoclasts,
following siRNA delivery, Ac45 mRNA and protein expression levels
were reduced by 80% and 50% respectively as determined by real-
time qPCR (Fig. 1B and C) and western blotting using a specific
polyclonal antibody against Ac45 (Fig. 1D). It should be noted that
newly synthesized Ac45 exists as precursor protein (ProAc45) of
,60kDa that is subsequently cleaved tothe maturefunctional form of
,45-kDa (Fig. 1D) by proprotein convertase Furin (Fig. S1) [24,28].
By comparison, gene expression levels of other known V-ATPase
subunits including V0 subunits a3, d2, c0 and c, and V1 subunits B2
and E1 remainedconstant following Ac45siRNA-mediated silencing,
attesting to the specificity of the siRNA (Ac1) to Ac45 (Fig. 1C).
An important function of V-ATPases in osteoclasts is to sustain
the acidification of intramembranous organelles [29]. Therefore,
as a first step towards investigating the function of Ac45 in
osteoclasts we assessed the impact of Ac45 gene knockdown on
osteoclastic intracellular acidification. To this end, we used
complementary acridine orange fluorescence quenching (AO)
and LysoSensor
TM Green DND-189 fluorescence detection assays
to probe intracellular acidification in control and Ac45 knockdown
osteoclasts [3,13,20,30–32].
As demonstrated in Figure 2D-F, Ac45-silenced precursors and
mature osteoclasts exhibit little AO quenching evidenced by the
predominantly green fluorescence upon overlay of the individual
488/543 fluorescence spectra. Little shift towards the red
fluorescence was observed, reflecting reduced acidity in Ac45
knockdown cells. In contrast, cells transfected with control siRNA
displayed typical intracellular acidification levels indicated by the
fluorescence shift of AO fluorescence from green to red (Fig. 2A–C).
Higher magnification (40X) and quantitative assessment further
exemplifies the quenching of AO in control osteoclasts but not in
Ac45-silenced osteoclasts as demonstrated by the green and red
fluorescence spectral overlays (Fig. 2G, H and K). Additionally,
LysoSensor
TM Green DND-189 further confirmed this intracellular
acidification defect in Ac45 knockdown osteoclasts. In this instance,
quantitative analysis of the LysoSensor
TM Green DND-189
fluorescence intensity (green) indicated that it was significantly
reduced in Ac45-silenced osteoclasts as compared to the control
siRNA transfected osteoclasts (Fig. 2I, J and L).
Because intracellular acidification by V-ATPases is also an
important requirement for endocytosis uptake [5–8,33,34], we
explored whether knockdown of Ac45 influenced the uptake of the
endocytic marker dextran (fluid-phase endocytosis) in BMM-
derived osteoclasts. Flow cytometric analysis revealed that knock-
down of Ac45 correlated with a reduction in rhodamine B-
conjugated dextran uptake when compared to that of the control
group (Fig. 3A). This observation was confirmed by morphometric
confocal assessment where significantly greater rhodamine B-
dextran uptake was observed in osteoclasts from the control siRNA
group as compared to those silenced for Ac45 (Fig. 3B).
Osteoclasts utilize V-ATPases clustered at the ruffled border to
synthesis and secrete high concentrations of H
+ protons into the
resorbingcompartmenttoremoveofmineralized bone matrix(need
referencehere).Given thedeficienciesobserved in both intracellular
acidification and endocytosis following Ac45 knockdown, two
processes known to be essential for bone resorptive function, we
analysed the effected of Ac45 suppression on the bone-resorptive
capacity of osteoclasts. To this end, osteoclasts transfected with
eitherAc45orcontrol siRNAswereculturedonbone discsfor48hrs
and analyzed for bone resorption by SEM. Osteoclastic bone
resorptive activity was significantly impaired upon the suppression
of Ac45 (Fig. 4A). Approximately two-third reduction in bone
resorption area was observed in Ac45-knockdown osteoclasts as
compared to controls (Fig. 4B). Furthermore, the average bone
resorption area per osteoclast (total area/total osteoclast number)
decreased by up to 50% in the Ac45-silenced group as compared to
control (Fig. 4C). Surprisingly, however, despite the obvious
resorptive defects, we found that Ac45 knockdown osteoclasts
exhibited incomplete or intermediate F-actin rings when compared
to control cells as visualized by Rhodamine-phalloidin staining
(Figure 4 D–I). These intermediate F-actin rings were smaller in size
and more numerous (Fig. 4H–I) and less well-organized per cell
following Ac45 knockdown (compared Fig. 4E to Fig. 4G).
Knockdown of Ac45 affects osteoclast formation and
maturation
Along with their canonical role in acidification and bone
resorption in osteoclasts, a subset of V-ATPase subunits have been
recently implicated in non-canonical functions in osteoclast
formation and maturation [13,20]. Consistently, knockdown of
Ac45 in pre-fusion osteoclasts stimulated with RANKL for 3 days
ledtoanumberofmorphologicalaberrationsinosteoclasts(Fig.5A).
Whereas the numberof TRAP+ve multinucleated osteoclasts with3
Roles of Ac45 in Osteoclasts
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siRNA control groups, (287612.12 and 269624.50 osteoclasts per
well respectively) (Fig. 5B), the average area occupied by individual
osteoclasts in the Ac45 siRNA group were significantly reduced
compared to that of the control group (,6000 mm
2 compared to
,12000 mm
2 respectively) (Fig. 5C). Furthermore, examination of
nuclei number per osteoclast revealed that siRNA-mediated
knockdown of Ac45 led to a significant reduction in the number
of osteoclaststhat possessed .15 nuclei per cell (Fig. 5D, white bars)
suggesting that suppression of Ac45 influences osteoclast fusion
and/or maturation. Similar results were obtained when Ac45 gene
expression was suppressed in BMM precursor cells prior to their
commitment to the osteoclast lineage (Day 0) with Ac45 knockdown
BMM precursor cells generating fewer and smaller TRAP+ve
Figure 1. Efficiency and specificity of Ac45 siRNA knockdown in osteoclasts. (A) Five Ac45 siRNA oligonucleotides were tested for their
ability to silence Ac45 mRNA expression. Semi-quantitative RT-PCR for Ac45 gene expression was carried out 48hrs post-transfection of siRNA oligos
(100nM) into pre-osteoclasts. Expression levels were normalized to 18S and expressed as percentage of control 6 SEM (n=3). (B) Specificity and
efficiency of Ac45 silencing. mRNA from pre-osteoclasts transfected with Ac45 siRNA for 48hrs was subjected to semi-quantitative RT-PCR analysis
using specific primers for V-ATPase V0 domain subunits a3 and d2, CTR and 18S. (C) Quantitative analysis of gene expression of Ac45 and V-ATPase
V1 (B2 and E1) and V0 (a3, d2, c0 and c) subunits following Ac45 silencing using real-time qPCR. Data represented as relative mRNA level normalized
to 36B4 control 6 SEM (n=3). (D) Ac45 protein level after Ac45 silencing in pre-osteoclasts for 48hrs. *P-values,0.05.
doi:10.1371/journal.pone.0027155.g001
Roles of Ac45 in Osteoclasts
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27155osteoclasts as compared with controls (69426400 mm
2 compared to
121386700 mm
2 respectively) (Fig. 5E–G). In an effort to identify a
possible mechanism throughwhich Ac45silencing altered osteoclast
formation, we further examined the protein expression of V0
domain subunits which have been implicated in membrane fusion
[13,20,35–39] in Ac45 knockdown pre-osteoclastic cells. Interest-
ingly, suppression of Ac45 expression substantially reduced the
protein level of V0 subunits a1, a3, d1 and d2 (Fig. 5H), although the
gene expression level was not changed (Fig. 1B and C), which may
indicate a destabilization of the V0 domain complex. In addition,
we also observed reduced protein expression levels of pro-fusogenic
proteins such as d2 and gene expression of ADAM8 (Fig. S2) which
may also, at least in part, account for the reduced osteoclast
formation and maturation phenotype observed given their previ-
ously assigned roles in membrane fusion [13,40]. Collectively, the
results suggest that Ac45 not only participates in canonical V-
ATPase functions of acidification and bone resorption but also in
non-canonical roles in osteoclast formation, fusion and maturation.
Ac45- Flox
Neo mice exhibit embryonic lethality
Finally, in an effort to reconcile these in vitro observations and
gain more precise insights into the role of Ac45 in osteoclasts, we
attempted to generate osteoclast-specific conditional Ac45 knock-
out mice by cross-breeding Ac45-Flox
Neo mice with Cathepsin K-
Cre knockin mice. For this purpose, a targeting vector floxing
exons 3 and 4 of Ac45 (Fig. 6A) was electroporated into 129ES
Figure 2. Ac45 is important for intracellular acidification in osteoclasts. Acridine orange (AO) staining of RANKL-stimulated BMM-derived
osteoclasts after Ctrl siRNA (A–C & G) or Ac45 siRNA (D–F & H) treatment for 48hrs under 10X magnification. Osteoclasts transfected with siRNAs
were incubated with 5 mg/ml AO for 30mins at 37uC followed by confocal microscopy. Cells were first excited with wavelength of 488nm and
emission wavelength of 522nm for unprotonated AO detection (A and D), followed by excitation wavelength of 543nm and emission wavelength of
580nm for protonated AO detection (B and E). Fluorescence shift of acridine orange from green to red indicate normal intracellular acidification. (C
and F) Image merge of red and green fluorescence spectra of Ctrl and Ac45 siRNA treated cells. (G and H) Higher magnification (40X) of merged
fluorescence spectra of a representative osteoclast from Ctrl and Ac45 siRNA treated population. (I and J) Osteoclasts were treated with 1 mg/ml
Lysosensor
TM Green DND-189 for 30min and excited at wavelength of 488nm. (K and L) The fluorescence intensity was quantified for both acridine
orange and LysosensorTM Green DND-189 and expressed as relative fluorescence intensity (n=3). *P-values,0.05.
doi:10.1371/journal.pone.0027155.g002
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clones were screened for floxed alleles by PCR (data not shown)
and southern blot analysis (Fig. 6B). Southern blot analysis
identified clones 2, 5 and 6 as positive ES clones with the
corresponding WT/KO band size of 14.8 and 7.1kB respectively
using 59-end and SphI digest screening, and 14.8 and 6.9kB
respectively using 3-end and SphI digest screening (Fig.6B). The
three positive ES clones were harvested for further blastocyst
injection. Initial embryos implanted to pseudopregnant females
failed to yield any viable mice due to embryonic lethality.
Subsequent implantations resulted in six embryos that survived
to E19.5. Tail-tip genotyping of these embryos identified embryos
1-to-5 as Ac45-Flox
Neo embryos with embryo 6 as WT (Fig. 6C).
Since global deletion of Ac45 has been previously reported to
result in early embryonic lethality due to impaired blastocyst
development [41], we probed the expression level of Ac45 in the
Ac45-Flox
Neo embryos by immunohistochemistry. In WT embryos
(E19.5) Ac45 was found to be ubiquitous and highly expressed in
the brain and skin (Fig. 6E). On the other hand, Ac45 expression
was not detected in the Ac45-Flox
Neo embryos (E19.5) (Fig. 6D
and E). Histological analysis of whole mount Ac45-Flox
Neo E19.5
embryos further revealed severely compromised embryonic
development, reminiscent of E12–13.5 WT embryos (as assessed
in detail in [42,43]) with impaired brain development, as
demonstrated by ventricular enlargement and significant neuronal
degeneration (Fig. 6D arrows and Fig. S3). While the precise
reason for the embryonic lethality is presently unknown, these
results provide further evidence for the importance of Ac45 in
mouse embryonic development.
Discussion
Accessory subunit Ac45 has been previously reported to co-
purify with the V0 domain of the V-ATPase sub complex and thus
is thought to constitute an integral component of the acidifying V-
ATPase proton pump [22,23]. Indeed, overexpression of Ac45
leads to increased granular acidification in Xenopus intermediate
pituitary melanotrope cells attesting to its functional contribution
to the V-ATPase acidification machinery [44]. In the present
study, we demonstrate that knockdown of Ac45 impairs
intracellular acidification in osteoclasts. In addition, suppression
of Ac45 led to a significant reduction in fluid-phase endocytosis in
osteoclastic cells suggesting that intracellular acidification is an
important requirement for endocytic uptake and cargo processing.
This position would be consistent with previous observations
employing bafilomycin A1, a V-ATPase inhibitor, which blocked
fluid-phase endocytosis in osteoclast precursor cells [45,46].
Furthermore, we demonstrate that depletion of Ac45 inhibited
the resorptive capacity of osteoclasts in vitro. Since osteoclastic
bone resorption is dependent on V-ATPase-mediated extracellular
acidification for the dissolution of the bone matrix as well as the
endocytic uptake of degraded bone matrix from the resorption
lacunae [34,47–49], it is not surprising that knockdown of Ac45
resulted in impairments in osteoclastic bone resorption cycle.
Together, our data lend support to the notion that, in osteoclasts,
Ac45 plays a role in canonical V-ATPase-mediated processes
including acidification and endocytosis and hence is an important
requirement of osteoclastic bone resorption.
An interesting observation in the present study is that Ac45
knockdown osteoclasts exhibit more numerous and smaller
intermediate/incomplete F-actin rings per osteoclast as compared
to the control. The precise reason for this discrepancy is presently
unclear. However, it is noteworthy to mention that similar
cytoskeletal disruptions have also been recently reported in
osteoclasts following the knockdown of the V-ATPase V1 domain
subunit C1 (ATP6V1C1) [50]. In this instance, the disruptions in
F-actin ring formation appear to be independent of its role in V-
ATPase activity given that the C subunit can bind and stabilize F-
actin assembly autonomously [51,52]. Thus it is conceivable that
Ac45 plays a similar role in regulating F-actin ring assembly in
osteoclasts. This position is further supported by our previous
observation demonstrating that Ac45 colocalizes with the F-actin
ring [10]. However, given that Ac45 knockdown decreased the
protein levels of other V0 domain subunits which may destabilize
the V0 domain complex, we cannot rule out the possibility that the
effect on F-actin ring formation is independent of Ac45. Indeed,
an intact V0 domain is a prerequisite for the assembly of the V1
domain with the V0 to form the V-ATPase complex. Thus the
destabilization of the V0 may have impaired V1/V0 assembly and
compromised V1-mediated F-actin ring formation. Future studies
will be required to delineate these possibilities.
Another unexpected morphological effect observed following
Ac45-depletion was the formation of smaller and fewer nucleated
osteoclasts. These surprising observations imply that in addition to
its role in the V-ATPase mediated acidification process; Ac45 may
regulate non-canonical roles during osteoclastogenesis. Indeed, this
Figure 3. Ac45 mediates fluid-phase endocytosis in osteoclasts
and their precursor cells. (A) Flow cytometric analysis of dextran-
rhodamine B uptake by Ac45 siRNA treated BMM-derived osteoclasts
and osteoclastic precursor cells. Cells transfected with siRNA oligos for
48hrs were treated with 50 mg/ml dextran-rhodamine B for 30mins
followed by flow cytometric analysis. The percentage of cells with
dextran-rhodamine B uptake was detected using 630/22nm bandpass
with at least 10,000 events collected and analyzed to determine the
proportion of cells containing dextran-rhodamine B and the geometric
mean of the positive population. (B) Dextran-rhodamine B uptake by
confocal microscopy. Osteoclasts treated with siRNA oligos were
incubated with 50 mg/ml dextran-rhodamine B for 30mins prior to
fixation for confocal analysis. Representative image of dextran-
rhodamine B uptake by Ac45-silenced and control-treated osteoclasts
from three independent experiments. Osteoclasts are indicated by the
white arrowheads.
doi:10.1371/journal.pone.0027155.g003
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subunit d2 knockout mice [13,20]. In this case, genetic ablation of
the d2 subunit led to profound defects in pre-osteoclast fusion with
no apparent intrinsic defect in osteoclast differentiation or V-
ATPase activity [13]. Additionally, expression of other pro-
fusogenic proteins such as DC-STAMP, ADAM8 and ADAM12
were also reduced in d2 knockout cells [40,53]. In line with this
effect, Ac45 suppression markedly reduced the protein levels of d2
and gene expression of ADAM8 and thus may also account for the
reduced osteoclast formation and maturation phenotype observed.
Moreover, there has been accumulating evidence to suggest that the
V0 domain complex partakes in membrane fusion [35–39],
however whether the entire V0 domain or specific subunits of the
V0 is important for osteoclastic precursor fusion remains unclear.
By comparison, loss or suppression of the V-ATPase a3 and C1
subunits demonstrate normal osteoclast differentiation and matu-
Figure 4. Ac45 is important for osteoclast bone resorption and F-actin ring formation. (A) Knockdown of Ac45 impairs bone resorption.
Ac45-silenced pre-osteoclasts cultured on bone discs for 48hrs were examined for bone resorptive activity by scanning electron microscopy (SEM). (B)
The area of bone resorptive pits in each bone disc was quantified as a percentage of the whole bone disc area. (C) The resorptive activity per
osteoclast was quantified as the average bone resorption area per osteoclast (%; total area/total osteoclast number). *P-values,0.05. (D and F) Low
magnification (20X) confocal analysis of F-actin ring formation in Ctrl and Ac45 siRNA treated osteoclasts cultured on bone discs. Ac45-silenced
osteoclasts cultured on bone discs were fixed and stained with rhodamine-conjugated phalloidin for the visualization of F-actin. Nuclei were
counterstained with Hoechst. (E and G) Higher magnification (60X) confocal analysis of dotted region in E and F respectively. Osteoclasts are
outlined in white. The average number of F-actin ring per osteoclast (H) and the average area ( mm
2) of F-actin rings (I) were quantified. Data
representative of three independent experiments (mean 6 SEM). *P-values,0.05.
doi:10.1371/journal.pone.0027155.g004
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defects [3,50]. Thus the current data suggests that specific V-
ATPase subunits possess both canonical and non-canonical V-
ATPase functions indicating that the role of V-ATPases in
osteoclasts formation and function may be more complex than
previously envisioned.
Finally, in an effort to elucidate the precise functional role that
Ac45 in physiological bone homeostasis in vivo, we attempted to
generate osteoclast-specific conditional knockout mice of Ac45.
However, an unanticipated embryonic lethality of Ac45-Flox
Neo
mice precluded the phenotypic assessment of Ac45 in osteoclasts of
conditional knockout mice. This unexpected result highlights an
important caveat that warrants consideration when designing
Ac45 conditional knockout lines. While the precise reason for the
embryonic lethality is currently under further investigation it
appears likely that the inclusion of the neomycin cassette
contributed to the lethality. In fact, recent studies indicate that
inclusion of the neomycin cassette in an intron of various floxed
genes can interfere with gene expression, compromising wildtype
activity in the absence of Cre-mediated recombination [54]. This
Figure 5. A role for Ac45 in osteoclast formation and fusion. (A) RANKL-stimulated pre-osteoclasts transfected with control or Ac45 siRNA for
48hrs were stained for TRAP activity to demonstrate multinucleated osteoclast formation. The number (B) and average size (mm
2)( C) of TRAP+ve
multinucleated osteoclasts (???3 nuclei) were quantified. (D) The number of nuclei per osteoclast from control and Ac45 siRNA treated groups. (E–G)
BMM precursors were silenced for Ac45 expression prior to commission to the osteoclast lineage and sustained following RANKL stimulation for
osteoclast formation. The number (F) and size (G) of resulting TRAP+ve osteoclasts were quantified. (H) Western blot analysis of protein expression of
V-ATPase V0 domain subunits a1, a3, d1, and d2 in osteoclasts following Ac45 gene silencing. Protein expression of a-tubulin was used as loading
control. Data representative of three independent experiments (mean 6 SEM). *P-values,0.05.
doi:10.1371/journal.pone.0027155.g005
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Neo mice with neomycin is embryonic lethal. (A) Strategy of generating Ac45-Flox
Neo mice. The Ac45-Flox
Neo mice was
generated by inserting two loxP sites in the intron upstream of exon 3 and another in the intron downstream of exon 4, with a neomycin-resistance
(neo) expression cassette inserted as a selection marker. (B) Southern blot of six ES clones (1–6) and a negative control. 59-SphI digest screening
reveals WT and KO band size of 14.8 and 7.1kB respectively. 39-SphI digest screening reveals WT and KO band size of 14.8 and 6.9kB respectively. (C)
Tail-tip genotyping of the embryos demonstrates that clones 1 to 5 were Ac45-Flox
Neo embryo (Ac45_FRT_tR1 and Neo3F primers produce a product
size of 429bp for floxed allele and no product for wildtype) while clone 6 is the WT embryo (Ac45_GF2 and Ac45_FRT_tR1 primers produce a product
size of 237bp for wildtype and no product for floxed). (D and E) Immunohistochemistry demonstrated Ac45 expression is ubiquitous and high in
brain and skin in the WT embryo whereas Ac45 expression was not detected in the Ac45-Flox
Neo embryo. In addition, the Ac45-Flox
Neo embryo had
ventricular enlargement and neuronal loss, demonstrating impairment of the brain development (arrows).
doi:10.1371/journal.pone.0027155.g006
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splice sites that interfere with normal splicing and thus reduce
wildtype mRNA levels [54,55]. It is interesting to note that
although our floxed mice survived to E19.5 of embryogenesis, the
actual developmental stage resembles E12–13.5 embryos, as
compared to the global knockout which impaired blastocyst
development [41]. This provides some indication that Ac45 was
likely expressed at an earlier point of embryonic development but
that the Ac45 levels were subsequently diminished possibly owing
to neomycin interference and thus was unable maintain Ac45
expression levels required for the survival of the embryo at later
stages of development. This may also account for the discrepancy
in our observations when compared to the global knockout where
targeted disruption of Ac45 occurred at the ES cell stage. Thus to
circumvent this problem and generate an osteoclast-specific Ac45
knockout, an alternative strategy would be to use three loxP sites to
flank the neomycin cassette and the region of interest of Ac45
gene. A partial Cre-mediated recombination can be carried out to
remove the neomycin cassette, leaving the region of interest of the
Ac45 gene floxed [56]. This approach is currently underway in
our laboratory and should hopefully yield further insights into this
perplexing V-ATPase accessory subunit.
In conclusion, the results of this study indicate that accessory
subunit Ac45 is an integral component of the osteoclast V-ATPase
machinery, regulating multiple facets of V-ATPase function
including canonical roles of acidification, endocytosis and bone
resorptionas well as and non-canonical roles in osteoclast formation
and maturation, suggesting that Ac45 is an important yet
remarkably versatile regulator of V-ATPase function.
Materials and Methods
Reagents and Antibodies
GST-RANKL160-318 (rRANKL) recombinant proteins were
expressed and purified in our laboratory as previously described
[57]. Mouse Ac45 silencing RNA (siRNA) oligonucleotides were
purchased from Santa Cruz Biotechnology, Dharmacon Inc.
(Thermo Scientific), and Shanghai GenePharma Co. Ltd.
HiPerfect and Lipofectamine2000 transfection reagent were
purchased from QIAGEN and Invitrogen respectively. Alexa
Fluor 647 Phalloidin, Dextran-Rhodamine B (10000MW), and
Hoechst 33258 were purchased from Invitrogen. Acridine orange
was purchased from Sigma, LysoSensor
TM Green DND-189
probe was purchased from Invitrogen, and Geneticin G418 sulfate
was purchased from Gibco. Rabbit polyclonal anti-Ac45 antibody
raised against the last 12-aa residues of mouse Ac45 was kindly
provided by Prof. E. Jansen from the Department of Molecular
Animal Physiology, University of Nijmegen, Netherlands [24].
The anti-Ac45 antibody was pre-cleared as previously described
[10]. Affinity purified rabbit polyclonal anti-d2 antibody was raised
against GST-d2 peptide antigen produced in our lab [21].
Cells and Cell Culture
Bone marrow monocytes (BMM) isolated from long bones of 6-
weeks old C57BL/6 mice were cultured in complete a-modified
Eagle’s medium (aMEM) (10% v/v fetal bovine serum (FBS),
2mM L-glutamine, 100u/ml penicillin, 100 mg/ml streptomycin)
supplemented with 10ng/ml M-CSF. Adherent M-CSF-depen-
dent osteoclast precursor cells were stimulated with 100ng/ml
rRANKL in the presence of 10ng/ml M-CSF for 5 days for the
formation of multinucleated osteoclasts. Cells positive for TRAP
activity and contained 3 or more nuclei were scored as mature
osteoclasts.
Semi-quantitative Reverse Transcription (RT)-PCR and
Real-time qPCR
Total cellular RNA was isolated from cultured cells using
RNeasy Mini Kit (QIAGEN) in accordance with the manufac-
turer’s protocol. For RT-PCR, single-stranded cDNA was reverse
transcribed from 2 mg total RNA using reverse transcriptase with
oligo-dT primer. All PCR was carried out using 2 ml of each
cDNA using the following cycling parameters 94uC, 40secs; 60uC,
40secs; and 72uC, 40secs for 30 cycles with primers shown in
Table S1. PCR samples were analyzed by DNA agarose gel
electrophoresis. For real-time qPCR analysis, corresponding PCR
primers were used as shown in Table S1 and performed on a 384-
well plate ABI Prism 7000 Sequence Detection system (Applied
BioSystems, USA) using SYBR Green PCR Master Mix
(QIAGEN). Cycling conditions was as follows 95uC, 15secs;
60uC, 20secs; and 72uC, 1min for 40 cycles. The comparative
2
2DDCT method was used to calculate the relative expression of
each target gene as previously described [58] and the expression
level of all genes were normalized to the expression level of the
house keeping gene 36B4.
Western Blot
Total cellular proteins were extracted from cultured cells using
RIPA RIPA lysis buffer (50mM Tris pH7.5, 150mM NaCl, 1% v/
v Nonidet P-40, 0.1% SDS, 1% sodium deoxycholate) supple-
mented with Protease Inhibitor Cocktail (Roche). Lysates were
cleared by centrifugation at 16,000g for 10mins at 4uC and
supernatant containing proteins were collected. For immunoblot-
ting, extracted proteins diluted in SDS-sampling buffer were
resolved by SDS-PAGE (10–15%) gels and then electroblotted
onto nitrocellulose membranes (Hybond ECL, Amersham Life
Science). Following transfer, membranes were blocked with 5%
w/v skim milk in TBS-Tween (TBS; 0.05M Tris, 0.15M NaCl,
pH7.5 and 0.2% v/v Tween-20) for 1hr and then probed with
primary antibodies diluted in 1% w/v skim milk powder in TBS-
Tween for 2hrs. Membranes were washed in TBS-Tween and
then incubated with HRP-conjugated secondary antibodies and
antibody reactivity was detected by the Enhanced Chemilumines-
cence (ECL) detection system (Amersham Biosciences) using the
FujiFilm LAS-3000 Gel Documentation System (FujiFilm) and its
associated software.
Silencing RNA Oligonucleotide Transfection
Ac45 and control (scrambled) siRNA oligos were transfected
into BMM-derived pre-osteoclasts (after 3 days 100ng/ml
rRANKL stimulation) to a final concentration of 100nM using
HiPerfect transfection reagent (QIAGEN) according to our
previously established protocol [59] . Gene knockdown efficiency
was validated 48hrs post-transfection by RT-PCR analysis as
described previously. Silenced osteoclasts were processed for bone
resorption, immunofluorescence, intracellular acidification, and
dextran uptake assays.
Intracellular Acidification
Intracellular acidification was determined by acridine orange
(AO) quenching and lysosensor fluorescence staining assays.
Silenced osteoclasts were serum-starved for 2hrs followed prior
to incubation with 5 mg/ml AO (Sigma) or 1 mg/ml lysosensor
TM
green DND-189 for 30mins at 37uC. Cells were washed and
processed for confocal microscopy analysis on a NIKON A1Si
spectral detector confocal system under 10X and 40X lenses. For
acridine orange quenching, cells were first excited with wavelength
of 488nm and emission wavelength of 522nm (unprotonated AO
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emission wavelength of 580nm (protonated AO detection).
Fluorescence shift of acridine orange from green to red indicates
normal intracellular acidification. For lysosensor
TM green DND-
189 fluorescence detection, cells were excited at wavelength of
488nm (lysosensor
TM green DND-189 will fluoresce when inside
acidic compartments and but no fluorescence can be detected if it
is inside neutral compartments). The signal intensity was measured
using the software accompanying the NIKON A1Si spectral
detector confocal system.
Fluid-Phase Dextran Uptake
BMM-derived pre-osteoclasts transfected with siRNA oligos for
48hrs were serum-starved for 2hrs followed by incubation with
50 mg/ml of Dextran-rhodamine B. Cells were washed and
processed for flow cytometric and/or confocal microscopic analysis.
Dextran-rhodamine B uptake by cells were analyzed on a Becton
Dickinson FACS Vantage (San Jose, California) instrument with a
488nm laser in the primary position and a 568nm laser in the
secondary position. Dextran-rhodamine B was detected using a
630/22nmbandpass filter infront ofFL5. Samplefilescontainingat
least10,000eventswere collectedusing CellQuest software(Version
3.1f, Becton Dickinson, San Jose, California) and analyzed to
determine both the proportion of cells containing Dextran and the
geometric mean of the positive population.
F-actin ring Immunofluorescence
For F-actin ring immunofluorescent staining, silenced osteo-
clasts cultured on bovine bone discs were fixed with 4%
paraformaldehyde for 15min at room temperature (RT) and
permeabilized for 5mins with 0.1% v/v Triton X-100. Cells were
incubated with rhodamine-conjugated phalloidin (1:100; Invitro-
gen) diluted in 0.2% w/v BSA-PBS for 1hr at RT and washed
extensively with 0.2% w/v BSA-PBS and PBS. Cells were then
incubated with Hoechst 3342 dye (1:5000; Invitrogen) for
visualization of nuclei, washed with PBS and mounted with
ProLong Gold anti-fade mounting medium (Invitrogen). Detection
of fluorescence was carried out on the NIKON A1Si spectral
detector confocal system equipped with 20X (dry) and 60X (oil)
lenses. Fluorescence images were collected using the systems NIS-
C Elements software and analysed using ImageJ.
Bone Resorption assay
Pre-osteoclasts seeded on bovine bone discs were silenced for
Ac45 gene expression as described above. Forty-eight hours post-
transfection, bone discs were fixed in 4% paraformaldehyde and
stained for TRAP activity. The number of TRAP+ve multinucle-
ated osteoclasts were scored prior to assessment of resorptive
activity. Resorption pits were visualized by scanning electron
microscopy. ImageJ (NIH) software was used to quantify bone
resorption parameters.
Generation of Ac45 conditional knockout mice
The Ac45 conditional allele (Ac45-Flox
Neo) was generated by
inserting loxP sites in the intron upstream of exon 3 and in the
intron downstream of exon 4, with a neomycin-resistance (neo)
expression cassette inserted as a selective marker for the ES cells
(Fig.1A). Cre-mediated deletion of the flanked sequence, would
delete exon 3 and 4 leading to frameshift mutation a null allele.
After construction of the targeting vector from a B6 BAC clone, the
plasmid was linearized by PacI digestion and eletroporated into
129ES cells. The transformants were selected for their G418 and
ganciclovir (Ganc) resistance. 39-end screening of ES cell DNA by
PCR using primers Ac45-C3R3: ACCTGTCCCCAGCACAAT-
CACATCG; and Neo3F: TCTGAGGCGGAAAGAACCAG; to
produce a band 4.8kb forheterozygous flox/wtandno band for wt/
wt; 59-end screening with primers: Ac45_loxp_tF1:
TTGTTCTTTGCTGTCCTCTTCCT and AC45_loxp_tR1:
CAGGCTAACAAAAGAGTGAACCATC; produced band of
497bp for heterozygous flox/wt and 231bp for wt/wt. ES clones
were subsequently screened by southern blot analysis using 59-SphI
(WT/KO band size of 14.8 and 7.1kB respectively) and 39-SphI
(WT/KOband sizeof14.8and6.9kBrespectively)digestscreening.
Flox
Neo+ve ES clones were subsequently injected into blastocyst and
transferred to pseudopregnant C57BL/6 ICR female mice. Tail-tip
genotyping was carried out with primers Ac45_FRT_tR1:
GGGCATTAGTGGTAACAAAGTTTTCTC and Neo3F:
TCTGAGGCGGAAAAGAACCAG to produce a product size of
429bpforfloxedallele and noproduct forwildtype;andAc45_GF2:
AGCCTCTAACCTTGCACCTCAG and Ac45_FRT_tR1 above
to produce a product size of 237bp for wildtype and no product for
floxed. This study was carried out in strict accordance with the
recommendations contained within the Australian Code of Practice
for the Care and Use of Animals for Scientific Purposes. The
protocol was approved by the Animal Ethics Committee (AEC) of
the University of Western Australia (Permit ID: RA/3/100/865).
Histology and Immunohistochemistry assessment of
Ac45-Flox
Neo Embryo
For morphological analysis, embryo specimens were fixed and
embedded in paraffin wax and then sectioned at a thickness of 5 mm
according to standard procedures. For immunohistochemistry,
antigen-retrieval using microwave heating was performed. Primary
antibodies against mouse Ac45 were used at a dilution of 1:1000.
Standard immunohistochemistry protocols were performed while
positive and negative controls were routinely included.
Statistics & Data Presentation
Results were statistically analyzed using a two-tailed Students T-
test using Microsoft Excel (Microsoft Corp.) and data shown
represent one of at least three independent experiments
Supporting Information
Figure S1 ProAc45 protein level following Ac45 silenc-
ing. Following 48hrs transfection with 100nM siRNA, total
cellular proteins were extracted from transfected mBMM as described
in Materials and Methods. Rabbit polyclonal anti-Ac45 antibody was
used to detect proAc45 and mature Ac45 [24]. Ac45 is produced as a
,62kDa precursor protein (proAc45) that is subsequently processed
into the mature ,45kDa form. The Ac45 siRNA appears to affect
both the proAc45 and mature Ac45 protein levels.
(TIF)
Figure S2 Quantitative analysis of Adam8 and Adam12
gene expression following Ac45 silencing using real-time
qPCR. mRNA from pre-osteoclasts transfected with Ac45 siRNA
for 48hrs was subjected to qPCR analysis using specific primers for
ADAM8 and ADAM12. Data represented as relative mRNA level
normalized to 36B4 control 6 SEM (n=3).
(TIF)
Figure S3 Comparison of WT wildtype E19.5 embryos
and Ac45-Flex
Neo embryo. H&E staining demonstrated that
well-developed brain structure in the wildtype E19.5 embryos
whilst the brain in Ac45-Flex
Neo embryo development is severely
impaired.
(TIF)
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